Back to today’s briefing

Story perspectives

Mount Sinai First to Use DBS for Depression Treatment

3/6/2025

30 4

Summary

Story summary

Mount Sinai has made history as the first U.S. center to implement deep brain stimulation (DBS) for treatment-resistant depression, joining Abbott's groundbreaking TRANSCEND trial. Under the leadership of Dr. Brian H. Kopell, this three-year study seeks to uncover the potential of DBS in transforming the lives of the 2.8 million Americans grappling with this debilitating condition each year.

1 of 1

Story summary

Mount Sinai has made history as the first U.S. center to implement deep brain stimulation (DBS) for treatment-resistant depression, joining Abbott's groundbreaking TRANSCEND trial. Under the leadership of Dr. Brian H. Kopell, this three-year study seeks to uncover the potential of DBS in transforming the lives of the 2.8 million Americans grappling with this debilitating condition each year.